Biopharma firm Thousand Oaks raises $64m led by CICC fund, Goldstone

Biopharma firm Thousand Oaks raises $64m led by CICC fund, Goldstone

Thousand Oaks Biopharmaceuticals Co., Ltd has raised 450 million yuan ($64 million) in a Series B round of financing jointly led by CICC Capital’s sub-fund CICC Jiatai and CITIC Securities’ private equity arm Goldstone Investment Limited. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter